Literature DB >> 4631704

An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.

A J Bazo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4631704     DOI： 10.1111/j.1532-5415.1973.tb01220.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  3 in total

Review 1.  Periodic health examination, 1991 update: 1. Screening for cognitive impairment in the elderly. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-02-15       Impact factor: 8.262

Review 2.  Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.

Authors:  A N Wadworth; P Chrisp
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

3.  Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; P Anderer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.